Endo International Stock Analysis (NASDAQ:ENDP)

Add to My Stocks
$13.19 $0.11 (0.84%) ENDP stock closing price Feb 21, 2017 (Closing)
Watch Robo Advisor Video of ENDP Stock Analysis
Endo International
Updated on : Feb 21, 2017
previous close
ENDP 13.2 (0%)
S&P 500 2365.4 (0%)
Closing Price On: Feb 21, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Drugs
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2016-Q3
$million
%
YOY GROWTH
Compared to the industry
Long Term Growth
5 Year CAGR:
9.5%
Operating Profit
Operating Margin:
-9.9%
Sector Average:
-1.1%
5 Quarter Net Profit
Net Margins
2016-Q3
%
LTM Margin
Debt/Equity Ratio
Debt:
8.29B
Debt/Equity Ratio:
 1.37
Compared to the industry
Cash Flow
Operating cash flow:
-$111.3M
Net Income:
-$218.9M
PROS      CONS
PE Valuation
PS Valuation
Long Term Growth
Operating Margins
Net Margins
High Debt Burden
ROE
FCF Margin
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
ENDP PS :
0.8
Industry PS :
4.6
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
1.7%
Return on Equity:
-2.1%
Free Cash Flow Margin:
-16.5%
Double Tap To Exit Full Screen
0:00
/

Endo International Analysis Video

248 6 2

View Endo International stock analysis video. This is our ENDP analyst opinion covering the buy and sell arguments for ENDP stock.

Endo International plc - Ordinary Shares Stock Rating (2.5/5)

Our Endo International stock opinion is based on fundamentals of the company. This Endo International stock analysis is based on latest Q3 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.

Should you buy ENDP stock?

  • The Endo International stock currently trades at a price to earnings ratio of 3.1. We rate this as a positive, compared to the industry average of 22.5.
  • ENDP stock is trading at a favorable price to sales multiple of 0.8 as against the Medical-Drugs industry average multiple of 4.6.

Should you sell ENDP stock?

  • Revenue growth of has been weak over the last 5 years.
  • Endo International registered a negative operating margin of -9.9% (average) over the Trailing Twelve Months (TTM).
  • Endo International registered an average TTM Net loss of -3.3%.
  • Endo International is debt laden and has a high debt/equity ratio of  1.37.
  • Endo International has a negative return on equity of -2.1%. This indicates that the firm is inefficient at generating profits.
  • The company has negative Free Cash Flows (FCF), with a negative FCF margin of -16.5%.

Comments on this video and Endo International stock